These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8101976)
1. Progress report from the testing program for stimulant and depressant drug (1992). Woolverton WL; Nader MA; Winger G; Woods JH; Patrick GA; Harris LS NIDA Res Monogr; 1993; 132():579-94. PubMed ID: 8101976 [No Abstract] [Full Text] [Related]
2. Progress report from the testing program for stimulant and depressant drugs (1996). France CP; Gerak LR; Rowlett JK; Woolverton WL; Winger G; Woods JH NIDA Res Monogr; 1998 Mar; 178():429-39. PubMed ID: 9686406 [No Abstract] [Full Text] [Related]
3. Progress report from the Testing Program for Stimulant and Depressant Drugs (1991). Winger G; Woods JH; Patrick GA; Powell LJ; Harris LS; Nader MA; Woolverton WL NIDA Res Monogr; 1992; 119():625-39. PubMed ID: 1359421 [No Abstract] [Full Text] [Related]
4. Progress report from the testing program for stimulant and depressant drugs (1993). Patrick GA; Harris LS; Woolverton WL; Nader MA; Winger G; Woods JH NIDA Res Monogr; 1994; 140():248-63. PubMed ID: 8722467 [No Abstract] [Full Text] [Related]
5. Testing drugs for abuse liability and behavioral toxicity: progress report from the laboratories at the Johns Hopkins University School of Medicine. Brady JV; Griffiths RR NIDA Res Monogr; 1983 Apr; 43():99-124. PubMed ID: 6135997 [No Abstract] [Full Text] [Related]
6. Biological evaluation of compounds for their physical dependence potential and abuse liability. XVI. Drug Evaluation Committee of the College of Problems of Drug Dependence, Inc. (1992). Jacobson AE NIDA Res Monogr; 1993; 132():437-58. PubMed ID: 8101975 [No Abstract] [Full Text] [Related]
7. Progress report from the Testing Program for Stimulant and Depressant Drugs (1990). Patrick GA; Harris LS; Nader MA; Woolverton WL; Winger G; Woods JH NIDA Res Monogr; 1992; 119():604-24. PubMed ID: 1359420 [No Abstract] [Full Text] [Related]
8. A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Johanson CE; Balster RL Bull Narc; 1978; 30(3):43-54. PubMed ID: 36945 [No Abstract] [Full Text] [Related]
9. Environmental modulation of the interoceptive effects of amphetamine in the rat. Paolone G; Palopoli M; Marrone MC; Nencini P; Badiani A Behav Brain Res; 2004 Jun; 152(1):149-55. PubMed ID: 15135978 [TBL] [Abstract][Full Text] [Related]
10. Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-administration after oral administration. Carroll FI; Fox BS; Kuhar MJ; Howard JL; Pollard GT; Schenk S Eur J Pharmacol; 2006 Dec; 553(1-3):149-56. PubMed ID: 17067572 [TBL] [Abstract][Full Text] [Related]
11. The guinea-pig isolated atrium as a model system for the central actions of selected CNS stimulant and depressant drugs. Part 1: 3,3-Diakylglutarimide homologues and related drugs. Arblaster CI; Cameron DW; Lavi Y; Laycock GM; Shulman A Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):503-47. PubMed ID: 2891885 [TBL] [Abstract][Full Text] [Related]
12. Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats. Bevins RA; Klebaur JE; Bardo MT Behav Pharmacol; 1997 Jun; 8(2-3):113-23. PubMed ID: 9833007 [TBL] [Abstract][Full Text] [Related]
13. Environmental context conditioning with ethanol reduces the aversive effects of ethanol in the acquisition of self-administration in rats. Krank MD; O'Neill S Psychopharmacology (Berl); 2002 Jan; 159(3):258-65. PubMed ID: 11862358 [TBL] [Abstract][Full Text] [Related]
14. Higher magnitude accumbal phasic firing changes among core neurons exhibiting tonic firing increases during cocaine self-administration. Ghitza UE; Prokopenko VF; West MO; Fabbricatore AT Neuroscience; 2006 Feb; 137(3):1075-85. PubMed ID: 16325346 [TBL] [Abstract][Full Text] [Related]